Knowles Q1 2025: Unpacking Contradictions on Inventory Levels, Tariffs, and Revenue Impact
Generated by AI AgentAinvest Earnings Call Digest
Friday, May 2, 2025 7:28 pm ET1min read
KN--
None
Tariff Exposure and Business Insulation:
- Knowles CorporationKN-- reported minimal direct tariff exposure, with less than 5% of revenue potentially subject to tariffs, and indirect exposure impacting less than 3% of cost of goods sold.
- The company's position is strengthened by its proximity manufacturing strategy, which reduces tariff impacts, and its focus on essential markets like MedTechMED-- and defense, which are historically less affected by economic downturns.
Q1 Financial Performance:
- KnowlesKN-- reported first-quarter revenue of $132 million, at the high end of the guided range, with EPS at $0.18, in line with the guided range.
- The results were driven by a strong performance in the Precision Device segment, offsetting the decline in MedTech and specialty audio revenue.
Precision Device Segment Outlook:
- The Precision Device segment achieved $73 million in revenue, flat compared to the previous quarter, while exceeding expectations.
- Improving production flow and yields in the specialty film line are expected to drive growth, with a larger ramp-up anticipated in the second half of the year.
Cash Generation and Share Repurchase:
- Knowles generated $1 million in cash from operating activities in Q1, exceeding the high end of the guided range.
- The company purchased $5 million worth of shares and reduced debt levels by $15 million, demonstrating strong cash management and commitment to capital allocation.
MedTech and Industrial Market Demand:
- MedTech and specialty audio revenue was $60 million, slightly up year-over-year, with a strong Q2 backlog.
- Demand in the industrial market remains robust, with no impact from tariffs thus far, as normalized inventory levels lead to increased order activity.
Tariff Exposure and Business Insulation:
- Knowles CorporationKN-- reported minimal direct tariff exposure, with less than 5% of revenue potentially subject to tariffs, and indirect exposure impacting less than 3% of cost of goods sold.
- The company's position is strengthened by its proximity manufacturing strategy, which reduces tariff impacts, and its focus on essential markets like MedTechMED-- and defense, which are historically less affected by economic downturns.
Q1 Financial Performance:
- KnowlesKN-- reported first-quarter revenue of $132 million, at the high end of the guided range, with EPS at $0.18, in line with the guided range.
- The results were driven by a strong performance in the Precision Device segment, offsetting the decline in MedTech and specialty audio revenue.
Precision Device Segment Outlook:
- The Precision Device segment achieved $73 million in revenue, flat compared to the previous quarter, while exceeding expectations.
- Improving production flow and yields in the specialty film line are expected to drive growth, with a larger ramp-up anticipated in the second half of the year.
Cash Generation and Share Repurchase:
- Knowles generated $1 million in cash from operating activities in Q1, exceeding the high end of the guided range.
- The company purchased $5 million worth of shares and reduced debt levels by $15 million, demonstrating strong cash management and commitment to capital allocation.
MedTech and Industrial Market Demand:
- MedTech and specialty audio revenue was $60 million, slightly up year-over-year, with a strong Q2 backlog.
- Demand in the industrial market remains robust, with no impact from tariffs thus far, as normalized inventory levels lead to increased order activity.
Discover what executives don't want to reveal in conference calls
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet